MPX Bioceutical Corporation

MPX Bioceutical Sales Rise 78% to $8 Million in Q4

MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018 Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation...
- August 2nd, 2018 at 3:29 pm

MPX Postpones Filing Date of 2018 Annual Statements

Company to reschedule conference call with shareholders upon finalization of financial results TORONTO, July 30, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC:...
- July 30th, 2018 at 4:56 pm

MPX to Report Fiscal 2018 Earnings on Monday, July 30, 2018

TORONTO, July 26, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) today announced the Company will issue its fiscal 2018 full-year results release on July...
- July 26th, 2018 at 8:56 am

MPX Enters California Cannabis Extracts Market

MPX Enters Into Extraction Agreement With Southern California’s Largest Cannabis Processing Facility, Case Farms Collective Relationship will provide a full scale operation of services to MPX’s proprietary specifications and...
- July 19th, 2018 at 9:00 am

MPX to Open First Maryland Cannabis Dispensary

MPX Secures Final Approval to Open First Managed Dispensary in Maryland; Schedules Grand Opening for August 4th Production of MPX-branded cannabis to commence at managed facility as Company’s Maryland...
- July 17th, 2018 at 9:27 am

MPX Appoints Robert Petch to the Board of Directors

TORONTO, June 06, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors...
- June 6th, 2018 at 7:48 pm

MPX to Acquire Canadian LP Canveda for $18 Million

MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda TORONTO, April 17, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to...
- April 17th, 2018 at 7:42 am

MPX Arizona Operations Post Record $4 Million Sales in March

Mpx Enjoys Record Monthly Revenue of Cdn$5.2 Million in Arizona TORONTO, April 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) has reported that its managed...
- April 3rd, 2018 at 7:49 am

MPX Bioceutical Reports FY18-Q3 Sales of $4.5 Million

MPX Reports Q3 Fiscal 2018 Results Execution of Expansion Strategy TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its...
- March 1st, 2018 at 7:42 am

MPX Bioceutical Expands Maryland Medical Cannabis Operations

MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is...
- January 31st, 2018 at 5:31 pm

MPX Bioceutical Names David McLaren as New CFO

MPX Appoints New Chief Financial Officer TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren...
- January 16th, 2018 at 7:55 am